Budget Impact Model (Bim) Of Rivaroxaban In Comparison With Enoxaparin Plus Warfarin In The Treatment Of Venous Thromboembolism (Vte) Under The Perspective Of The Private Health System

Abstract

A383significantly increased from 18% to 25% with carvedilol and bisoprolol versus metoprolol tartrate. Our primary findings were consistent through various sensitivity analyses. ConClusions: We suggest that there is no evidence of a differential effect of β -blockers on mortality in older patients with HF, but the agent selected may have an impact on the rate of HF readmissions.